The Current Ratio of ESSA Pharma Inc (EPIX) is
38.79.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2024-09-30 |
38.79
|
| 2023-09-30 |
42.57
|
| 2022-09-30 |
73.52
|
| 2021-09-30 |
50.67
|
| 2020-09-30 |
66.92
|
| 2019-09-30 |
9.70
|
| 2018-09-30 |
4.73
|
| 2017-09-30 |
1.34
|
| 2016-09-30 |
2.78
|
| 2015-09-30 |
3.38
|
| Ticker |
Name |
Value |
|
ITOS
|
iTeos Therapeutics Inc
|
12.75
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
0.06
|
|
AKRO
|
Akero Therapeutics Inc
|
19.25
|
|
CYDY
|
Cytodyn Inc
|
0.26
|
|
EPZM
|
Epizyme Inc
|
4.56
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
9.39
|
|
RPTX
|
Repare Therapeutics Inc
|
6.84
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.82
|
|
MRSN
|
Mersana Therapeutics Inc
|
2.19
|
|
KNSA
|
Kiniksa Pharmaceuticals International, PLC
|
3.79
|
|
PCVX
|
Vaxcyte, Inc.
|
7.91
|
|
PRTA
|
Prothena Corporation PLC
|
7.72
|
|
AFMD
|
Affimed NV
|
3.25
|
|
APS.TO
|
Aptose Biosciences Inc
|
0.78
|
|
AVXL
|
Anavex Life Sciences Corp
|
11.60
|
|
CRTX
|
Cortexyme Inc
|
7.85
|
|
FUSN
|
Fusion Pharmaceuticals Inc
|
15.01
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
4.40
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
13.42
|
|
ADVM
|
Adverum Biotechnologies Inc
|
5.73
|
|
DVAX
|
Dynavax Technologies Corp
|
10.80
|
|
ORIC
|
ORIC Pharmaceuticals, Inc.
|
14.13
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
10.22
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
3.90
|
|
ANNX
|
Annexon, Inc.
|
5.68
|
|
PASG
|
Passage Bio Inc
|
2.07
|
|
BTAI
|
BioXcel Therapeutics Inc
|
0.83
|
|
SVA.V
|
Sernova Corp
|
19.19
|
|
TH.TO
|
Theratechnologies Inc
|
1.19
|
|
TRIL.TO
|
Trillium Therapeutics Inc
|
13.95
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
2.92
|
|
ARCT
|
Arcturus Therapeutics Holdings Inc
|
6.64
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
4.41
|
|
TSHA
|
Taysha Gene Therapies, Inc.
|
12.23
|
|
ZYME
|
Zymeworks Inc.
|
5.88
|